ATE145672T1 - Neue inhibitoren für hydrolytische enzyme und substrate und bestimmungsverfahren, selbige einschliessende verfahren und testsätze - Google Patents

Neue inhibitoren für hydrolytische enzyme und substrate und bestimmungsverfahren, selbige einschliessende verfahren und testsätze

Info

Publication number
ATE145672T1
ATE145672T1 AT90913627T AT90913627T ATE145672T1 AT E145672 T1 ATE145672 T1 AT E145672T1 AT 90913627 T AT90913627 T AT 90913627T AT 90913627 T AT90913627 T AT 90913627T AT E145672 T1 ATE145672 T1 AT E145672T1
Authority
AT
Austria
Prior art keywords
substrates
methods
tests
hydrolytic enzymes
new inhibitors
Prior art date
Application number
AT90913627T
Other languages
English (en)
Inventor
Edward A Dennis
William N Washburn
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23581012&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE145672(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE145672T1 publication Critical patent/ATE145672T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
    • C12Q2334/10—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases p-Nitrophenol derivatives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918—Carboxylic ester hydrolases (3.1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT90913627T 1989-08-29 1990-08-17 Neue inhibitoren für hydrolytische enzyme und substrate und bestimmungsverfahren, selbige einschliessende verfahren und testsätze ATE145672T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39979989A 1989-08-29 1989-08-29

Publications (1)

Publication Number Publication Date
ATE145672T1 true ATE145672T1 (de) 1996-12-15

Family

ID=23581012

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90913627T ATE145672T1 (de) 1989-08-29 1990-08-17 Neue inhibitoren für hydrolytische enzyme und substrate und bestimmungsverfahren, selbige einschliessende verfahren und testsätze

Country Status (8)

Country Link
US (2) US5427919A (de)
EP (1) EP0489839B1 (de)
JP (1) JP3100057B2 (de)
AT (1) ATE145672T1 (de)
AU (1) AU643952B2 (de)
CA (1) CA2064793C (de)
DE (1) DE69029269T2 (de)
WO (1) WO1991003544A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3100057B2 (ja) * 1989-08-29 2000-10-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 新規な加水分解酵素阻害剤及び基質、並びにこれらを用いた分析方法及びキット
AU4058297A (en) * 1996-08-08 1998-02-25 Children's Hospital Medical Center Of North America Phospholipase a2 as a marker for the presence of pulmonary fat embolism
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
US6264937B1 (en) * 1998-01-09 2001-07-24 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US6299868B1 (en) 1999-07-14 2001-10-09 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US7048917B1 (en) 1998-01-09 2006-05-23 Genzyme Corporation Fat-binding polymers
GB0111987D0 (en) * 2001-05-16 2001-07-04 Univ Sheffield Method
US7049345B2 (en) * 2001-06-29 2006-05-23 Genzyme Corporation Fat-binding polymers
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
WO2003101177A2 (en) * 2002-06-04 2003-12-11 Sequenom, Inc. Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
US20050014158A1 (en) * 2002-06-27 2005-01-20 Adam Gail Isabel Reid Therapeutic methods for reducing fat deposition and treating associated conditions
WO2004002295A2 (en) * 2002-06-27 2004-01-08 Sequenom, Inc. Diagnosing predisposition to fat deposition and associated condition
US7041469B2 (en) * 2002-10-10 2006-05-09 Quidel Corporation Assays for trichomonal and other hydrolases
FR2847267B1 (fr) * 2002-11-19 2006-07-28 Coletica Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2
CN110452262A (zh) * 2019-08-22 2019-11-15 深圳上泰生物工程有限公司 血小板激活因子(paf)类似物的合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833152A (en) * 1980-03-05 1989-05-23 University Of Miami Anti-hypertensive agents
DE3011061C2 (de) * 1980-03-21 1983-12-22 Siemens AG, 1000 Berlin und 8000 München Verfahren zur Intensivierung von Spül- und Reinigungsprozessen für Perforationen in Formstücken in Spül- und Reinigungsautomaten
FI63064C (fi) * 1980-04-09 1983-04-11 Ksv Chemicals Oy Foerfarande foer fluorometrisk bestaemning av aktiviteten av fettspjaelkande enzymer och medel foer att genomfoera foerfarandet
US4447445A (en) * 1983-08-03 1984-05-08 The Regents Of The University Of Calif. Manoalide, an anti-inflammatory analgesic marine natural product
US4616089A (en) * 1983-08-03 1986-10-07 University Of California Synthetic anti-inflammatory derivatives of manoalide
US4826958A (en) * 1984-12-14 1989-05-02 Abbott Laboratories Renin inhibiting compounds
JP2757987B2 (ja) * 1985-04-15 1998-05-25 バイオテクノロジー リサーチ パートナーズ，リミテッド ヒト抗‐炎症ホスホリパーゼ阻害蛋白
DE3516001A1 (de) * 1985-05-03 1986-11-06 Boehringer Mannheim Gmbh, 6800 Mannheim Lipasefarbtest
US4835099A (en) * 1986-11-20 1989-05-30 Becton, Dickinson And Company Signal enhancement in immunoassay by modulation of enzymatic catalysis
US4788304A (en) * 1987-12-07 1988-11-29 American Home Products Corporation Phospholipase A2 inhibitors
DE3807123A1 (de) * 1988-03-04 1989-09-14 Boehringer Mannheim Gmbh Substrate fuer phospholipasen
FR2628914B1 (fr) * 1988-03-18 1990-06-29 Alcatel Thomson Faisceaux Recepteur pour systeme de transmission par voie hertzienne a diversite d'espace, comprenant un combineur de diversite
US5308766A (en) * 1989-08-29 1994-05-03 The Regents Of The University Of California Hydrolytic enzyme inhibitors/inactivators and methods for using same
US5352673A (en) * 1989-08-29 1994-10-04 Dennis Edward A Prodrugs
JP3100057B2 (ja) * 1989-08-29 2000-10-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 新規な加水分解酵素阻害剤及び基質、並びにこれらを用いた分析方法及びキット
US5314815A (en) * 1992-03-04 1994-05-24 The Catholic University Of America Method for temporarily inhibiting or deactivating serine hydrolase and adduct of serine hydrolase with a phosphonate or phosphate compound

Also Published As

Publication number Publication date
DE69029269T2 (de) 1997-05-28
EP0489839B1 (de) 1996-11-27
CA2064793A1 (en) 1991-03-01
AU643952B2 (en) 1993-12-02
EP0489839A4 (en) 1992-10-28
CA2064793C (en) 2001-11-13
DE69029269D1 (de) 1997-01-09
JPH05500157A (ja) 1993-01-21
AU6353090A (en) 1991-04-08
WO1991003544A1 (en) 1991-03-21
EP0489839A1 (de) 1992-06-17
US5427919A (en) 1995-06-27
JP3100057B2 (ja) 2000-10-16
US5567597A (en) 1996-10-22

Similar Documents

Publication Publication Date Title
ATE145672T1 (de) Neue inhibitoren für hydrolytische enzyme und substrate und bestimmungsverfahren, selbige einschliessende verfahren und testsätze
ATE279203T1 (de) Verwendung von substrat-subtraktionsbibliotheken zur unterscheidung von enzymspezifitäten
ATE193330T1 (de) Reporterenzym-freisetzungstechnologie: verfahren zum nachweis der gegenwart von aspartat-proteasen und anderen aktivitaeten von hydrolytischen enzymen
ATE7900T1 (de) Chromogene verbindungen und ihre verwendung als enzymsubstrate.
Haynes et al. Transformation of active-site lysine in naturally occurring trypsin inhibitors. A basis for a general mechanism for inhibition of proteolytic enzymes
AT349648B (de) Verfahren zur bestimmung von enzymen des typus serinproteasen, bei dem aminosaeurereste ent- haltende chromogene substrate durch diese enzyme gespalten werden
ATE233325T1 (de) Fluoreszenz-basierte hts-(high throughput screening)assayverfahren für proteinkinase und phosphatase
PT73005B (de) Mittel zum nachweis esterolytischer und/oder proteolytischer enzyme und dafur geeignete substrate
HUP0100079A2 (hu) Új, fluoreszcens riportermolekulák és alkalmazásaik, többek között kaszpázok vizsgálatára
DE69735127D1 (de) Enzymsensor
DE69528614D1 (de) Modifizierte Proenzyme als Substrate für proteolische Enzyme
ATE1296T1 (de) Substratzusammensetzung und ihre verwendung.
Andrews et al. Inhibition of four human serine proteases by substituted benzamidines
ATE333510T1 (de) Enzymatische messung von mycophenolsäure
DE60119965D1 (de) Verfahren und medium zum nachweisen/identifizieren von mikroorganismen mit esterase- und/oder osidase- und/oder peptidase- und/oder sulfatase- und/oder phosphataseaktivität
ATE238551T1 (de) Homogene nachweisverfahren zur bestimmung der phosphorylierungsaktivitäten von biologischem material
DE60225271D1 (de) Screening auf enzyminhibitoren
ES552374A0 (es) Un procedimiento para determinar la actividad de una hidrolasa macromolecular
ATE36557T1 (de) Verfahren zur bestimmung der wirksamkeit von substraten oder enzymen.
Willemse et al. The intrinsic enzymatic activity of plasma procarboxypeptidase U (TAFI) can interfere with plasma carboxypeptidase N assays
MY104675A (en) Chromogenic substrate for esterase and immunoassay using same.
Markland Jr et al. Comparison of two methods for proteolytic enzyme detection in snake venom
DE3778259D1 (de) Verfahren zur differenzial-bestimmung von amylase-isoenzymen und satz dafuer.
JPS6434298A (en) Method for fractionating and determining alpha-amylase isozyme
MAN et al. A COMPARATIVE STUDY OF URINARY

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties